<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7BAFA7C5-8CB7-42E9-B0E1-4E2DA259F254"><gtr:id>7BAFA7C5-8CB7-42E9-B0E1-4E2DA259F254</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Henderson</gtr:otherNames><gtr:surname>McVey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120074259"><gtr:id>D4CDF75F-2134-4636-8AAE-92869AEDE888</gtr:id><gtr:title>Haemostasis &amp;amp; Thrombosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120074259</gtr:grantReference><gtr:abstractText>The group investigates blood clotting mechanisms and particularly the causes of thrombosis and haemophilia. Our research includes the biochemistry and structure of coagulation proteins, the molecular genetics of thrombophilia and haemophilia and the cellular biology of blood vessels. Diseases of blood vessels and thrombosis are among the most prevalent causes of premature death in Western society. Advances in the basic science of these conditions are urgently needed to find ways of preventing the onset of disease and to improve the treatment of affected individuals.</gtr:abstractText><gtr:technicalSummary>The aim of our research is to use clinical, genetic and biochemical approaches, to further our understanding of the regulation and function of activated coagulation factors and their role in thrombosis, bleeding, wound repair and restenosis; and to enable the development of novel disease treatment strategies.Tissue factor (TF) exposure to flowing blood is crucial in coagulation initiation, while amplification of the process involves a number of factors. We are studying TF expression and regulation in vivo, using transgenic animal models. Mouse models are being generated and characterised in which a reporter gene sequence encoding green fluorescent protein (GFP) has been introduced by homologous recombination resulting in expression of a TF-GFP fusion protein that allows direct visualisation of TF expression in vivo. In addition transgenic mouse models expressing targeted tethered anticoagulant molecules have been used to assess the contribution of activated coagulation factors to the processes of wound repair and vascular remodelling. The success of these strategies in preventing intimal hyperplasia and consumptive coagulopathy observed in edotoxemia has led us to begin to develop novel therapeutics based on these strategies that will deliver targeted-tethered anticoagulants to sites of vascular injury. These involve the use of single chain antibody fusion molecules but also viral gene delivery. Systemic delivery of adenovirus to different target organs is limited by hepatic uptake. We have recently shown that adenovirus transduction of hepatocytes is mediated by coagulation factors, in particular factor X. We are currently investigating the molecular mechanism through which this is mediated and developing novel strategies that will allow us to specifically block hepatocyte uptake allowing delivery of adenovirus to specific target organs.The genetic basis of clinical haemostatic disorders are also investigated. We are also developing resequencing technologies that will allow rapid identification of the genetic cause of common blood coagulation disorders. Thus aiding the clincial management of these diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2008-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1993-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1343474</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>An optimized coding sequence of human blood clotting factor eight (VIII) and a promoter may be used in vectors, such as rAAV, for introduction of factor VIII, and/or other blood clotting factors and transgenes. Exemplary of these factors and transgenes are alpha- 1 -antitrypsin, as well as those involved in the coagulation cascade, hepatocye biology, lysosomal storage, urea cycle disorders, and lipid storage diseases. Cells, vectors, proteins, and glycoproteins produced by cells transformed by the vectors and sequence, may be used in treatment.</gtr:description><gtr:grantRef>MC_U120074259</gtr:grantRef><gtr:id>DDCB50F6-2BC3-4F3D-A312-B6EA2EFCD37C</gtr:id><gtr:impact>Human gene therapy trial for haemophilia A http://www.biomarin.com/hemophilia-a</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58b58f7ccfbbb3.83195876</gtr:outcomeId><gtr:patentId>WO2011005968</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>CODON-OPTIMIZED FACTOR VI I I VARIANTS AND SYNTHETIC LIVER-SPECIFIC PROMOTER</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Factor VII deficiency is caused by variants in the gene that codes for coagulation factor VII. There are currently 139 unique variants in the F7 gene compiled within this database corresponding to 330 individual cases.</gtr:description><gtr:id>60AB34FC-880D-4E06-9C13-BB1BBDF49461</gtr:id><gtr:impact>The original publication describing the database has been cited 151 times. The new site has been visited 1772 times since going live in March 2015.</gtr:impact><gtr:outcomeId>58b591bb569e41.05259182</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EAHAD Factor VII gene (f7) variant database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.factorvii.org/</gtr:url></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>11956FFB-22E3-40E5-B71A-108219A812F5</gtr:id><gtr:title>Regulated endothelial cell expression of novel anticoagulants: a strategy for the prevention and therapy of intravascular thrombosis.</gtr:title><gtr:parentPublicationTitle>Transplantation proceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7c701d8e064a4012140c494c65b7417"><gtr:id>a7c701d8e064a4012140c494c65b7417</gtr:id><gtr:otherNames>Dorling A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0041-1345</gtr:issn><gtr:outcomeId>pm_13670_10_10936303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD4AE7E1-DE2E-48BE-8AE5-48FBD3A6328A</gtr:id><gtr:title>Molecular Analysis in Factor XI Deficiency.</gtr:title><gtr:parentPublicationTitle>Methods in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1629befa8a3e55c16486a55e8d16058"><gtr:id>e1629befa8a3e55c16486a55e8d16058</gtr:id><gtr:otherNames>Johnson KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>1543-1894</gtr:issn><gtr:outcomeId>pm_13670_20_21340997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B361F3CC-228F-415D-8B1B-D7E6CE004AB6</gtr:id><gtr:title>The importance of tissue factor source in the management of Factor VII deficiency.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00abb53d0c7077ddeabcee055924d7b9"><gtr:id>00abb53d0c7077ddeabcee055924d7b9</gtr:id><gtr:otherNames>Bolton-Maggs PH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_17200783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF1B5815-D8E5-4820-97E2-ACAC0D594731</gtr:id><gtr:title>450 million years of hemostasis.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e09aa5eb437975fbe1a45727a1494418"><gtr:id>e09aa5eb437975fbe1a45727a1494418</gtr:id><gtr:otherNames>Davidson CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_13670_10_12871284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97429B48-D2D0-4156-95EF-F3FECDBC9309</gtr:id><gtr:title>Tissue factor pathway.</gtr:title><gtr:parentPublicationTitle>Bailliere's best practice &amp; research. Clinical haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:outcomeId>pm_13670_10_10856975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4860077E-38C0-4128-9A0A-B450EC21CB38</gtr:id><gtr:title>Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3230e9bdf916d9a8073a96a50cc24fc8"><gtr:id>3230e9bdf916d9a8073a96a50cc24fc8</gtr:id><gtr:otherNames>Mumford AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_10_14617013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21AC46C3-4B38-4161-A9B1-B610BEEFDECF</gtr:id><gtr:title>Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58bd982cab8a60042179ea90e8a88a7"><gtr:id>b58bd982cab8a60042179ea90e8a88a7</gtr:id><gtr:otherNames>Lalloz MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_770_7918076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE6250B2-D4E4-4609-B6E8-F4E96786F1BA</gtr:id><gtr:title>Characterization of a recent retroposon insertion on mouse chromosome 2 and localization of the cognate parental gene to chromosome 11.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c5a7edc115b71b92cf491d31145a3c1"><gtr:id>3c5a7edc115b71b92cf491d31145a3c1</gtr:id><gtr:otherNames>Palmer DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>pm_13670_970_9457668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E6BB346-8FE6-4F02-910E-02ABFD37920F</gtr:id><gtr:title>Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_10_18268094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD2BE349-BBBC-4B1D-A4A4-38D472FC4E7B</gtr:id><gtr:title>Haemophilia A diagnosis by automated fluorescent DNA detection of ten factor VIII intron 13 dinucleotide repeat alleles.</gtr:title><gtr:parentPublicationTitle>Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/078cfc807cb8ace2b42c993dae432c45"><gtr:id>078cfc807cb8ace2b42c993dae432c45</gtr:id><gtr:otherNames>Kochhan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0957-5235</gtr:issn><gtr:outcomeId>pm_13670_770_7841304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>738504F9-805D-4355-B4E2-9C63649C35B3</gtr:id><gtr:title>A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbdc4aada47f930d898c5741e8800aff"><gtr:id>fbdc4aada47f930d898c5741e8800aff</gtr:id><gtr:otherNames>Albrecht C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_10_15790791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>612988E8-257D-4FF9-930E-872DA4D20236</gtr:id><gtr:title>Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_13670_10_16803463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA119322-8D98-49BA-8279-089AA6410ADE</gtr:id><gtr:title>Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_13670_10_10515384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE3DE32B-1D84-4FF3-B7C6-B19C21F20BCD</gtr:id><gtr:title>Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87d13b1a560a142d23f444e9b9994402"><gtr:id>87d13b1a560a142d23f444e9b9994402</gtr:id><gtr:otherNames>Neerman-Arbez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_10_10090934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44088F9B-EA09-4C6F-8255-E9D292285FB8</gtr:id><gtr:title>Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54f41728e220a66a15fac108f33cb875"><gtr:id>54f41728e220a66a15fac108f33cb875</gtr:id><gtr:otherNames>O'Brien DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_13670_770_7947828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>266467E0-626E-471C-ACC4-FBE28FBF1079</gtr:id><gtr:title>Inhibition of coagulation by macromolecular complexes.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ae9e6dd96b6380530a61d4ef1bf4a75"><gtr:id>8ae9e6dd96b6380530a61d4ef1bf4a75</gtr:id><gtr:otherNames>Gomez K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>pm_13670_10_16266906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F31A00F8-F183-4944-8235-ABD6764FB824</gtr:id><gtr:title>The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cde94d1f481dbfec78410ba48be6520"><gtr:id>4cde94d1f481dbfec78410ba48be6520</gtr:id><gtr:otherNames>Tak?cs K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13670_10_15520381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABB0B9E4-0E5B-4391-87E3-C403F7CCE15D</gtr:id><gtr:title>Generation of a polyclonal rabbit anti-mouse tissue factor antibody by nucleic acid immunisation.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3230e9bdf916d9a8073a96a50cc24fc8"><gtr:id>3230e9bdf916d9a8073a96a50cc24fc8</gtr:id><gtr:otherNames>Mumford AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_15630507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>647547BF-6FAB-4FA4-9B4E-487F5F3DE50D</gtr:id><gtr:title>Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfa80ad7118bf8e4022403efccd6bcd9"><gtr:id>cfa80ad7118bf8e4022403efccd6bcd9</gtr:id><gtr:otherNames>Riesbeck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_970_9423800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F06F91CE-F74B-4CFB-B363-FE73A3CA7527</gtr:id><gtr:title>Characterisation of lymphocyte responses to Ca2+ in Scott syndrome.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f38aa2f3e0662719938dc0eaea694dc"><gtr:id>5f38aa2f3e0662719938dc0eaea694dc</gtr:id><gtr:otherNames>Elliott JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_14961172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0F4BEC5-AF00-4660-859E-6DF315DFFA10</gtr:id><gtr:title>Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37ad02443c8a13325ab1a72e307dd092"><gtr:id>37ad02443c8a13325ab1a72e307dd092</gtr:id><gtr:otherNames>Zhang B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13670_10_12717434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8700905-71CE-454F-8F5D-2987BE7CFE14</gtr:id><gtr:title>Molecular evolution of the vertebrate blood coagulation network.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e09aa5eb437975fbe1a45727a1494418"><gtr:id>e09aa5eb437975fbe1a45727a1494418</gtr:id><gtr:otherNames>Davidson CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_12624623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFD3C89A-9AC1-4EAC-BEEB-1C34030CDFDD</gtr:id><gtr:title>Interferon-gamma modulates prolactin and tissue factor expression in differentiating human endometrial stromal cells.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a670826c8d08acb87b84facda2a14fd"><gtr:id>1a670826c8d08acb87b84facda2a14fd</gtr:id><gtr:otherNames>Christian M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_13670_10_11416037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>133B1093-74BA-4907-A49B-E91A30A0CD57</gtr:id><gtr:title>The interface between coagulation and immunity.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55f40bc5b0102e5288d97d23e4c64c60"><gtr:id>55f40bc5b0102e5288d97d23e4c64c60</gtr:id><gtr:otherNames>Shrivastava S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>pm_13670_10_17229071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A21111D-E055-4C7F-A9BD-3C05782753A4</gtr:id><gtr:title>Your bleeding heart: lessons from low tissue factor expression in mice.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>pm_13670_10_12823950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F1FA3E5-F537-4535-937B-F5CC05E88BB2</gtr:id><gtr:title>Domains of invasion organelle proteins from apicomplexan parasites are homologous with the Apple domains of blood coagulation factor XI and plasma pre-kallikrein and are members of the PAN module superfamily.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e08316cab1131a30e71a1102d740c8a"><gtr:id>1e08316cab1131a30e71a1102d740c8a</gtr:id><gtr:otherNames>Brown PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>pm_13670_10_11376658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>535E6736-2CFD-4A2C-AD92-5CD051919B16</gtr:id><gtr:title>Molecular genetic analysis of factor XI deficiency: identification of five novel gene alterations and the origin of type II mutation in Portuguese families.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/262ddbf9daa0e3d0954f656acda406c8"><gtr:id>262ddbf9daa0e3d0954f656acda406c8</gtr:id><gtr:otherNames>Ventura C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_11127865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6940C18C-47E7-4F07-8EB1-E79E2E5FC842</gtr:id><gtr:title>Adenovirus serotype 5 hexon mediates liver gene transfer.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64b66eaea7d42ff1967dc761a5272e25"><gtr:id>64b66eaea7d42ff1967dc761a5272e25</gtr:id><gtr:otherNames>Waddington SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_13670_10_18267072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>098CA838-2294-4472-90FB-A260B93687D8</gtr:id><gtr:title>Factor VIIShinjo: a dysfunctional factor VII variant homozygous for the substitution Gln for Arg at position 79.</gtr:title><gtr:parentPublicationTitle>Haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fb7b4a7846313cdc64d954047c1201"><gtr:id>35fb7b4a7846313cdc64d954047c1201</gtr:id><gtr:otherNames>Takamiya O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0301-0147</gtr:issn><gtr:outcomeId>pm_13670_770_7607584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A43F9D5F-9A09-426E-A4B0-FAAF1C81FC3C</gtr:id><gtr:title>Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0aa3df1963a7045e867bf82306d36f1"><gtr:id>f0aa3df1963a7045e867bf82306d36f1</gtr:id><gtr:otherNames>Nathwani AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_770_7803234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E0B15AD-C3F3-46C8-A04C-FFFA9531D31C</gtr:id><gtr:title>A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52eed325db93f913d490edfd21367512"><gtr:id>52eed325db93f913d490edfd21367512</gtr:id><gtr:otherNames>Connolly DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1993-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_13670_870_8245452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C224FAA-164F-4611-B5F5-11080B6CAFFE</gtr:id><gtr:title>Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3255449e696d020b16d9f79aaaca0aa4"><gtr:id>3255449e696d020b16d9f79aaaca0aa4</gtr:id><gtr:otherNames>Bachli EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_13670_10_12941034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68EE511A-A23D-4643-BDFB-DB7DDB2C4213</gtr:id><gtr:title>Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.</gtr:title><gtr:parentPublicationTitle>Xenotransplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0908-665X</gtr:issn><gtr:outcomeId>pm_13670_10_11737851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA945B37-C676-4920-8866-5C897D64712A</gtr:id><gtr:title>Factor VII deficiency and the FVII mutation database.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_13670_10_11139238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84D49CB9-F334-4E02-B895-7C2D222E4F02</gtr:id><gtr:title>Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>pm_13670_10_15575897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04C867EB-C7AD-450E-A38C-BC6AC78276F5</gtr:id><gtr:title>Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79e9721f5a2f10f46ee67b879fc7f565"><gtr:id>79e9721f5a2f10f46ee67b879fc7f565</gtr:id><gtr:otherNames>Parker AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_10_16788098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28AB279-1864-484E-885E-B5E892786502</gtr:id><gtr:title>Tissue factor in the myocardium: evidence of roles in haemostasis and inflammation.</gtr:title><gtr:parentPublicationTitle>Disease markers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3230e9bdf916d9a8073a96a50cc24fc8"><gtr:id>3230e9bdf916d9a8073a96a50cc24fc8</gtr:id><gtr:otherNames>Mumford AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0278-0240</gtr:issn><gtr:outcomeId>pm_13670_10_15665396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DCC6281-FC14-469E-826C-A002CB67993D</gtr:id><gtr:title>High-grade stereo acuity after early surgery for congenital esotropia.</gtr:title><gtr:parentPublicationTitle>Archives of ophthalmology (Chicago, Ill. : 1960)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06281e36c42cf614496009cc5ec758e1"><gtr:id>06281e36c42cf614496009cc5ec758e1</gtr:id><gtr:otherNames>Wright KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0003-9950</gtr:issn><gtr:outcomeId>pm_13670_870_8031270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB6EC1C7-6B27-4281-87B1-B13FDB41073B</gtr:id><gtr:title>Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_970_9680360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A92F0E7-C120-41D7-93B4-18DEBCD85CD3</gtr:id><gtr:title>Coagulation factor VII Gln100 --&amp;gt; Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5090e2c719bf3ae124b45b98e84d4124"><gtr:id>5090e2c719bf3ae124b45b98e84d4124</gtr:id><gtr:otherNames>Kemball-Cook G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13670_970_9525966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ACAE726-1571-4961-952E-497FB3600B56</gtr:id><gtr:title>Molecular analysis of the genotype-phenotype relationship in factor VII deficiency.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e543cf56b4021a120b64f8f56372f938"><gtr:id>e543cf56b4021a120b64f8f56372f938</gtr:id><gtr:otherNames>Millar DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>pm_13670_10_11129332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE020F95-B834-495F-91C1-758800543B1F</gtr:id><gtr:title>Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c920fa404ca95ee2f86883a9d791d1"><gtr:id>86c920fa404ca95ee2f86883a9d791d1</gtr:id><gtr:otherNames>Houston P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_13670_970_9974408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87C5CC1A-B1D3-41A1-93F3-DF93074A548F</gtr:id><gtr:title>Six point mutations that cause factor XI deficiency.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a95bbad9226f791e71d57013396602ba"><gtr:id>a95bbad9226f791e71d57013396602ba</gtr:id><gtr:otherNames>Pugh RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_770_7888672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81700C0D-2720-483E-A0C4-20DD06AD2E3F</gtr:id><gtr:title>The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f38aa2f3e0662719938dc0eaea694dc"><gtr:id>5f38aa2f3e0662719938dc0eaea694dc</gtr:id><gtr:otherNames>Elliott JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>pm_13670_10_15899033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEC5D0EF-7757-405C-A101-DC1E9814FAD1</gtr:id><gtr:title>Characterisation of blood coagulation factor XI T475I.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_15968392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A157B53E-5A66-4BDE-A5B2-4E94662CE0A8</gtr:id><gtr:title>Staden Plus.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_13670_870_8004163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE5F9229-B929-4010-83A0-21D01ED3F81C</gtr:id><gtr:title>A Tyr346--&amp;gt;Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3230e9bdf916d9a8073a96a50cc24fc8"><gtr:id>3230e9bdf916d9a8073a96a50cc24fc8</gtr:id><gtr:otherNames>Mumford AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_10_12139751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54177394-F391-4F8B-8B43-9BF685E22D57</gtr:id><gtr:title>Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_13670_10_10030296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A239A04-607E-40A1-8297-3344A7E281AC</gtr:id><gtr:title>In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f88cc0b3857e4454158c5b9ddf455220"><gtr:id>f88cc0b3857e4454158c5b9ddf455220</gtr:id><gtr:otherNames>Wang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13670_10_18753195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BC0BFC0-042B-4D33-B909-99680D3CE1AC</gtr:id><gtr:title>High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector.</gtr:title><gtr:parentPublicationTitle>Gene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5090e2c719bf3ae124b45b98e84d4124"><gtr:id>5090e2c719bf3ae124b45b98e84d4124</gtr:id><gtr:otherNames>Kemball-Cook G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0378-1119</gtr:issn><gtr:outcomeId>pm_13670_870_8112618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7386B20-F270-4B2A-ACC9-90C9B73F970D</gtr:id><gtr:title>Tissue factor initiated blood coagulation.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience : a journal and virtual library</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ae9e6dd96b6380530a61d4ef1bf4a75"><gtr:id>8ae9e6dd96b6380530a61d4ef1bf4a75</gtr:id><gtr:otherNames>Gomez K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1093-4715</gtr:issn><gtr:outcomeId>pm_13670_10_16368521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4363BEC1-D271-4925-A0BA-2F784861F9CE</gtr:id><gtr:title>The genetic basis of inhibitor development in haemophilia A.</gtr:title><gtr:parentPublicationTitle>Haemophilia : the official journal of the World Federation of Hemophilia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c5a836b0d8d51b577e980c7b4c843a6"><gtr:id>9c5a836b0d8d51b577e980c7b4c843a6</gtr:id><gtr:otherNames>Tuddenham EG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>1351-8216</gtr:issn><gtr:outcomeId>pm_13670_970_9873791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7440392C-E9FC-4D15-A2BD-B2847CA8EE52</gtr:id><gtr:title>Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfa80ad7118bf8e4022403efccd6bcd9"><gtr:id>cfa80ad7118bf8e4022403efccd6bcd9</gtr:id><gtr:otherNames>Riesbeck K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_13670_970_9851962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02BC92BE-7035-4AD1-8BA0-096C93AFDD07</gtr:id><gtr:title>Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_13670_10_18606855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1BDDC2E-D63D-4330-A218-D1C4B08001E6</gtr:id><gtr:title>Tissue factor pathway.</gtr:title><gtr:parentPublicationTitle>Bailliere's clinical haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1994-01-01</gtr:date><gtr:issn>0950-3536</gtr:issn><gtr:outcomeId>pm_13670_770_7841596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC6349D8-C698-45BF-8E6F-514E0D0F76CE</gtr:id><gtr:title>An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequence.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f66693869ec210c5eff82736ba19ba76"><gtr:id>f66693869ec210c5eff82736ba19ba76</gtr:id><gtr:otherNames>Shibata M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_10_11019969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>290DD0C4-129E-47C2-9299-6B82BFD9625B</gtr:id><gtr:title>Analysis of the F8 gene in individuals with high plasma factor VIII: C levels and associated venous thrombosis.</gtr:title><gtr:parentPublicationTitle>Thrombosis and haemostasis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bf46c89216d18559eafa6bc9a1448df"><gtr:id>6bf46c89216d18559eafa6bc9a1448df</gtr:id><gtr:otherNames>Mansvelt EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0340-6245</gtr:issn><gtr:outcomeId>pm_13670_970_9798969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C84171-EAE7-4ACD-9166-D1F86ACD2FB0</gtr:id><gtr:title>A G--&amp;gt;A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP).</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5708332d42498a7fd3febdefb4f760ee"><gtr:id>5708332d42498a7fd3febdefb4f760ee</gtr:id><gtr:otherNames>McVey JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1993-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13670_770_7684942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDF9767C-FEB8-43F6-9556-2730ABACE722</gtr:id><gtr:title>Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da775c3c3de734a3fc6025ab4f8f7751"><gtr:id>da775c3c3de734a3fc6025ab4f8f7751</gtr:id><gtr:otherNames>Lin CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_13670_10_18791452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0341667-E22C-4999-9748-491BDAAE66AC</gtr:id><gtr:title>Identification of two novel mutations in non-Jewish factor XI deficiency.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e021896ab59f19bb5b8a1a990e5e1790"><gtr:id>e021896ab59f19bb5b8a1a990e5e1790</gtr:id><gtr:otherNames>Imanaka Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1995-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_770_7669672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD8D4FA-3FC2-47A5-BB71-ECF356E4A066</gtr:id><gtr:title>Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65791c99bda1101209907bdbe1e29c83"><gtr:id>65791c99bda1101209907bdbe1e29c83</gtr:id><gtr:otherNames>Steen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_10_14695241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B85DDD62-8E8A-4FB3-A69A-ED29A4299E0B</gtr:id><gtr:title>Analysis of the consequences of premature termination codons within factor VIII coding sequences.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b4a2feb6c47233bb950f885e7f25d67"><gtr:id>4b4a2feb6c47233bb950f885e7f25d67</gtr:id><gtr:otherNames>David D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_13670_10_12871551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C45A2BCB-6F49-4CE6-B2B5-C4F90A590A2C</gtr:id><gtr:title>Two novel mutations in severe factor VII deficiency.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ae9e6dd96b6380530a61d4ef1bf4a75"><gtr:id>8ae9e6dd96b6380530a61d4ef1bf4a75</gtr:id><gtr:otherNames>Gomez K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_10_15198740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB2CD31D-6469-480E-B4CB-9471B0A9619F</gtr:id><gtr:title>Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b4a2feb6c47233bb950f885e7f25d67"><gtr:id>4b4a2feb6c47233bb950f885e7f25d67</gtr:id><gtr:otherNames>David D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_10_11380445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2034881-5415-4FFD-BDC6-CA448F8FD7C0</gtr:id><gtr:title>Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/450f3ec1002a6e2f18ae542cd11bffbb"><gtr:id>450f3ec1002a6e2f18ae542cd11bffbb</gtr:id><gtr:otherNames>Morichika S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1997-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_13670_970_9326186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF2C88CA-F323-46E4-926A-0BA74713005E</gtr:id><gtr:title>Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13670_10_15126322</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120074259</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>